{"id":9831,"date":"2019-09-11T11:05:41","date_gmt":"2019-09-11T11:05:41","guid":{"rendered":"https:\/\/colorectalcc.wpengine.com\/non-classifiee\/clinically-meaningful-survival-benefit\/"},"modified":"2024-08-06T18:37:10","modified_gmt":"2024-08-06T18:37:10","slug":"publication-un-avantage-significatif-sur-le-plan-clinique-en-matiere-de-survie-avec-le-ccrm-refractaireclinically-meaningful-survival-benefit","status":"publish","type":"post","link":"https:\/\/www.colorectalcancercanada.com\/fr\/blogue\/publication-un-avantage-significatif-sur-le-plan-clinique-en-matiere-de-survie-avec-le-ccrm-refractaireclinically-meaningful-survival-benefit\/","title":{"rendered":"Publication: Un avantage significatif sur le plan clinique en mati\u00e8re de survie avec le CCRm r\u00e9fractaire"},"content":{"rendered":"<p class=\"p_imgevent\">C\u2019est avec plaisir que Cancer colorectal Canada (CCC) vous annonce la publication de l\u2019articleintitul\u00e9 \u00ab What is a clinically meaningful survival benefit in refractory metastatic colorectal cancer? \u00bb (Qu\u2019est-ce qui constitue un avantage significatif sur le plan clinique en mati\u00e8re de survie chez les patients atteints d\u2019un cancer colorectal m\u00e9tastatique qui sont r\u00e9fractaires au traitement?), qui est le fruit d\u2019une r\u00e9union de concertation organis\u00e9e par CCC. Nous remercions chaleureusement les auteurs de l\u2019article et esp\u00e9rons que celui-ci s\u2019av\u00e9rera utile pour r\u00e9pondre aux questions d\u2019\u00e9quit\u00e9 et de transparence relatives \u00e0 l\u2019\u00e9valuation des technologies de la sant\u00e9. <u><a href=\"https:\/\/current-oncology.com\/index.php\/oncology\/article\/view\/4753\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/current-oncology.com\/index.\u2026\/oncology\/article\/\u2026\/4753<\/a><\/u><\/p>\n<div class=\"b_imgn\"><img decoding=\"async\" src=\"https:\/\/www.colorectalcancercanada.com\/wp-content\/uploads\/2023\/08\/Article-Image.jpg\" \/><\/div>\n","protected":false},"excerpt":{"rendered":"<p>C\u2019est avec plaisir que Cancer colorectal Canada (CCC) vous annonce la publication de l\u2019articleintitul\u00e9 \u00ab What is a clinically meaningful survival benefit in refractory metastatic colorectal cancer? \u00bb (Qu\u2019est-ce qui constitue un avantage significatif sur le plan clinique en mati\u00e8re de survie chez les patients atteints d\u2019un cancer colorectal m\u00e9tastatique <a href=\"https:\/\/www.colorectalcancercanada.com\/fr\/blogue\/publication-un-avantage-significatif-sur-le-plan-clinique-en-matiere-de-survie-avec-le-ccrm-refractaireclinically-meaningful-survival-benefit\/\">&#8230;<\/a><\/p>\n","protected":false},"author":2,"featured_media":9229,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"0","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"footnotes":""},"categories":[42],"tags":[],"class_list":["post-9831","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blogue"],"_links":{"self":[{"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/posts\/9831","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/comments?post=9831"}],"version-history":[{"count":0,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/posts\/9831\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/media\/9229"}],"wp:attachment":[{"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/media?parent=9831"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/categories?post=9831"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/tags?post=9831"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}